The complete nucleotide sequence of the Ni neuraminidase gene of influenza virus A/USSR/90/77 was determined. Comparison of its predicted amino acid sequence with other NI and N2 neuraminidases indicates that the Ni neuraminidases share most of the antigenic determinants mapped on the N2 neuraminidase but display at least one additional potentially antigenic region probably as a result of intersubtypic differences in glycosylation.
The complete nucleotide sequence of the Ni neuraminidase gene of influenza virus A/USSR/90/77 was determined. Comparison of its predicted amino acid sequence with other NI and N2 neuraminidases indicates that the Ni neuraminidases share most of the antigenic determinants mapped on the N2 neuraminidase but display at least one additional potentially antigenic region probably as a result of intersubtypic differences in glycosylation.
Influenza A virus displays two virus-specified glycoprotein antigens. hemagglutinin (HA). the major antigen. and neuraminidase (NA), a minor antigen. The capability of the virus to strongly vary these antigens by at least two general mechanisms allows the virus to continue to circulate in human and animal populations despite the ability of the hosts to mount immune responses against these viral antigens. In an attempt to better understand this variation, we undertook the determination of the nucleotide sequences of the genes encoding the surface antigens of influenza virus A/USSR/90/ 77.
We report here the nucleotide sequence of the A/USSR! 90/77 NA gene. The coding sequence is 1.413 nucleotides in length, encoding 470 amino acids. This sequence was determined by the dideoxy chain termination method (8) from four cDNA clones generated by specific priming and reverse transcription of viral genomic RNA segments (3) . All of these clones contained the entire NA-coding sequence but varied in the amount of the untranslated regions at the 5' and 3' ends that they contained. The sequence of the A/USSR/ 90/77 NA gene is shown in Fig. 1 When amino acid differences in N2 field strains and in vitro-selected variants are superimposed on the three-dimensional structure of the neuraminidase molecule, they cluster into seven regions that have the potential of being involved in antibody interaction (1) . as judged by their accessibility and variability. The regions have been numbered I through VII, and we have adopted this nomenclature in our sequence comparisons. These families of determinants defined for N2 are listed in Table 2 along with their positions in our sequence alignment in Fig. 1 Family VIll is a novel family of determinants defined in the text for the NI neuraminidase.
The amino acid substitutions we observed at this site strongly suggest that such interaction has occurred during circulation in vivo to select variants at this position.
Our comparison of Ni NA sequences yields two significant conclusions. First, the finding that differences in glycosylation may result in differences in the organization of antigenic sites in NA molecules of different subtypes confirms previous observations made for the HA molecule, indicating that this may be a general mechanism employed by influenza A viruses. Second. the comparison of the locations of the highly variable regions of the NI and N2 NA molecules is a stringent test of whether the gross threedimensional structures of the molecules are similar, since these areas are those most likely to display differences between subtypes. The striking similarity in the locations of these sites is a strong argument that the Ni and N2 NA molecules share similar structures.
